Cargando…

Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows

The main objective of this study was to quantify the effect of pegbovigrastim (PEG) as an adjunct therapy for naturally occurring severe mastitis cases on survival, intramammary bacteriological cure, and subsequent milk production. A double-blinded, randomized controlled trial was conducted on a sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis-Robichaud, J., Christophe, M., Roy, J.-P., Buczinski, S., Rousseau, M., Villettaz Robichaud, M., Dubuc, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623706/
https://www.ncbi.nlm.nih.gov/pubmed/36337107
http://dx.doi.org/10.3168/jdsc.2021-0137
_version_ 1784822063910879232
author Denis-Robichaud, J.
Christophe, M.
Roy, J.-P.
Buczinski, S.
Rousseau, M.
Villettaz Robichaud, M.
Dubuc, J.
author_facet Denis-Robichaud, J.
Christophe, M.
Roy, J.-P.
Buczinski, S.
Rousseau, M.
Villettaz Robichaud, M.
Dubuc, J.
author_sort Denis-Robichaud, J.
collection PubMed
description The main objective of this study was to quantify the effect of pegbovigrastim (PEG) as an adjunct therapy for naturally occurring severe mastitis cases on survival, intramammary bacteriological cure, and subsequent milk production. A double-blinded, randomized controlled trial was conducted on a single commercial dairy farm. During the study period, all cows having a case of severe clinical mastitis, defined as the presence of abnormal milk and inflammation in one quarter or more combined with the presence of systemic signs (pyrexia, dehydration, or recumbency), were enrolled in the study. In addition to a standardized therapy combining systemic and intramammary antimicrobials as well as systemic anti-inflammatory drugs, cows received a subcutaneous injection of either 2.7 mL of 0.9% sterile saline (control group; CON) or 2.7 mL of PEG (PEG group). A milk sample for bacteriological analysis was taken before treatment was administered and a second sample was taken 14 d after enrollment. Survival (30 d post-treatment) and bacteriological cure (14 d post-treatment) were analyzed by survival analysis and chi-squared tests, respectively, whereas daily milk production was treated as a repeated measure in mixed regression models. The 77 cows enrolled in the study were of parity 2 to 4 (mean = 3) and between 3 and 302 d in milk (mean = 154). The bacteria identified in milk at enrollment were Klebsiella spp. (n = 48; 62%), Escherichia coli (n = 16; 21%), Enterobacter spp. (n = 10; 13%), or no growth (n = 3; 4%). The probability of survival during the first 30 d after treatment was higher in the PEG group (84%) than in the control group (46%). Daily milk production over the 30-d period following treatment and bacteriological cure 14 d post-treatment did not differ between groups. Overall, cows treated with PEG as an adjunct therapy for naturally occurring cases of severe clinical mastitis had a better survival than cows treated with saline.
format Online
Article
Text
id pubmed-9623706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96237062022-11-04 Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows Denis-Robichaud, J. Christophe, M. Roy, J.-P. Buczinski, S. Rousseau, M. Villettaz Robichaud, M. Dubuc, J. JDS Commun Health, Behavior, and Well-being The main objective of this study was to quantify the effect of pegbovigrastim (PEG) as an adjunct therapy for naturally occurring severe mastitis cases on survival, intramammary bacteriological cure, and subsequent milk production. A double-blinded, randomized controlled trial was conducted on a single commercial dairy farm. During the study period, all cows having a case of severe clinical mastitis, defined as the presence of abnormal milk and inflammation in one quarter or more combined with the presence of systemic signs (pyrexia, dehydration, or recumbency), were enrolled in the study. In addition to a standardized therapy combining systemic and intramammary antimicrobials as well as systemic anti-inflammatory drugs, cows received a subcutaneous injection of either 2.7 mL of 0.9% sterile saline (control group; CON) or 2.7 mL of PEG (PEG group). A milk sample for bacteriological analysis was taken before treatment was administered and a second sample was taken 14 d after enrollment. Survival (30 d post-treatment) and bacteriological cure (14 d post-treatment) were analyzed by survival analysis and chi-squared tests, respectively, whereas daily milk production was treated as a repeated measure in mixed regression models. The 77 cows enrolled in the study were of parity 2 to 4 (mean = 3) and between 3 and 302 d in milk (mean = 154). The bacteria identified in milk at enrollment were Klebsiella spp. (n = 48; 62%), Escherichia coli (n = 16; 21%), Enterobacter spp. (n = 10; 13%), or no growth (n = 3; 4%). The probability of survival during the first 30 d after treatment was higher in the PEG group (84%) than in the control group (46%). Daily milk production over the 30-d period following treatment and bacteriological cure 14 d post-treatment did not differ between groups. Overall, cows treated with PEG as an adjunct therapy for naturally occurring cases of severe clinical mastitis had a better survival than cows treated with saline. Elsevier 2021-08-20 /pmc/articles/PMC9623706/ /pubmed/36337107 http://dx.doi.org/10.3168/jdsc.2021-0137 Text en © 2021. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Health, Behavior, and Well-being
Denis-Robichaud, J.
Christophe, M.
Roy, J.-P.
Buczinski, S.
Rousseau, M.
Villettaz Robichaud, M.
Dubuc, J.
Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title_full Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title_fullStr Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title_full_unstemmed Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title_short Randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
title_sort randomized controlled trial of pegbovigrastim as an adjunct therapy for naturally occurring severe clinical mastitis cases in dairy cows
topic Health, Behavior, and Well-being
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623706/
https://www.ncbi.nlm.nih.gov/pubmed/36337107
http://dx.doi.org/10.3168/jdsc.2021-0137
work_keys_str_mv AT denisrobichaudj randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT christophem randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT royjp randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT buczinskis randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT rousseaum randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT villettazrobichaudm randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows
AT dubucj randomizedcontrolledtrialofpegbovigrastimasanadjuncttherapyfornaturallyoccurringsevereclinicalmastitiscasesindairycows